Literature DB >> 24356923

A cascade leading to premature aging phenotypes including abnormal tumor profiles in Werner syndrome (review).

Masanobu Sugimoto1.   

Abstract

This perspective review focused on the Werner syndrome (WS) by addressing the issue of how a single mutation in a WRN gene encoding WRN DNA helicase induces a wide range of premature aging phenotypes accompanied by an abnormal pattern of tumors. The key event caused by WRN gene mutation is the dysfunction of telomeres. Studies on normal aging have identified a molecular circuit in which the dysfunction of telomeres caused by cellular aging activates the TP53 gene. The resultant p53 suppresses cell growth and induces a shorter cellular lifespan, and also compromises mitochondrial biogenesis leading to the overproduction of reactive oxygen species (ROS) causing multiple aging phenotypes. As an analogy of the mechanism in natural aging, we described a hypothetical mechanism of premature aging in WS: telomere dysfunction induced by WRN mutation causes multiple premature aging phenotypes of WS, including shortened cellular lifespan and inflammation induced by ROS, such as diabetes mellitus. This model also explains the relatively late onset of the disorder, at approximately age 20. Telomere dysfunction in WS is closely correlated with abnormality in tumorigenesis. Thus, the majority of wide and complex pathological phenotypes of WS may be explained in a unified manner by the cascade beginning with telomere dysfunction initiated by WRN gene mutation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356923     DOI: 10.3892/ijmm.2013.1592

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.

Authors:  Renuka Kandhaya-Pillai; Deyin Hou; Jiaming Zhang; Xiaomeng Yang; Goli Compoginis; Takayasu Mori; Tamara Tchkonia; George M Martin; Fuki M Hisama; James L Kirkland; Junko Oshima
Journal:  Geroscience       Date:  2021-01-05       Impact factor: 7.713

Review 2.  Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming.

Authors:  Akira Shimamoto; Koutaro Yokote; Hidetoshi Tahara
Journal:  Front Genet       Date:  2015-01-29       Impact factor: 4.599

Review 3.  RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers.

Authors:  Kazunobu Futami; Yasuhiro Furuichi
Journal:  Front Genet       Date:  2015-01-09       Impact factor: 4.599

Review 4.  Insights into the Conserved Regulatory Mechanisms of Human and Yeast Aging.

Authors:  Rashmi Dahiya; Taj Mohammad; Mohamed F Alajmi; Md Tabish Rehman; Gulam Mustafa Hasan; Afzal Hussain; Md Imtaiyaz Hassan
Journal:  Biomolecules       Date:  2020-06-09

Review 5.  Replication Stress at Telomeric and Mitochondrial DNA: Common Origins and Consequences on Ageing.

Authors:  Pauline Billard; Delphine A Poncet
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

Review 6.  DNA damage-how and why we age?

Authors:  Matt Yousefzadeh; Chathurika Henpita; Rajesh Vyas; Carolina Soto-Palma; Paul Robbins; Laura Niedernhofer
Journal:  Elife       Date:  2021-01-29       Impact factor: 8.140

7.  Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer.

Authors:  Momoyo Nishioka; Shinji Kamei; Tomoe Kinoshita; Junpei Sanada; Yoshiro Fushimi; Shintaro Irie; Yurie Hirata; Akihito Tanabe; Hidenori Hirukawa; Tomohiko Kimura; Atsushi Obata; Fuminori Tatsumi; Kenji Kohara; Masashi Shimoda; Shuhei Nakanishi; Tomoatsu Mune; Kohei Kaku; Hideaki Kaneto
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

8.  Identification of polymorphisms in cancer patients that differentially affect survival with age.

Authors:  Aoife Doherty; Yelena Kernogitski; Alexander M Kulminski; João Pedro de Magalhães
Journal:  Aging (Albany NY)       Date:  2017-10-20       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.